trial · primary record
Carboplatin
Recurrent Lung Non-Small Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 660 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Overall survival (OS) |
| Registry ID | NCT04092283 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:35.028Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04092283
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.